Irbesartan Improves Endothelial Dysfunction, Abnormal Lipid Profile, Proteinuria and Liver Dysfunction in Zucker Diabetic Fatty Rats Independent of Glucose and Insulin Levels

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2011.307